Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03938324 · ClinicalTrials.gov registry record · NA

Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions

A NA study of Sickle Cell Disease and Cystic Fibrosis, sponsored by Duke University.

Completed
Registry status
NA
Development phase
222
Enrollment target
1
Study location

NCT03938324 is a NA study of Sickle Cell Disease and Cystic Fibrosis that has completed, run by Duke University. The registered enrollment target is 222 participants, below the 292-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03938324, a NA study of Sickle Cell Disease and Cystic Fibrosis, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
222 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test the efficacy of a peer support coaching intervention to improve activated chronic illness self-management versus an attention control group in 225 adolescents and young adults with childhood onset chronic conditions.

Interventions

  • BEHAVIORAL PiCASO Intervention Group
  • BEHAVIORAL Sham Comparator: Attention Control Group

Study Locations (1)

North Carolina

  • Duke University - Durham

Trial Details

FieldValue
Enrollment Target 222 participants
Start Date 2019-10-29
Est. Completion 2024-06-19
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT03938324

The ClinicalTrials.gov registry entry for NCT03938324 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 222 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 292-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (24% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 9 conditions, with Sickle Cell Disease appearing as the primary indexed condition, and to 2 interventions - of which PiCASO Intervention Group is the first listed.

NCT03938324 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT03938324 about?

NCT03938324 is a clinical study titled "Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions". The purpose of this study is to test the efficacy of a peer support coaching intervention to improve activated chronic illness self-management versus an attention control group in 225 adolescents and young adults with childhood onset chronic conditions.

What is the current status of trial NCT03938324?

This trial is currently completed. It is a NA study. The enrollment target is 222 participants. The study started on 2019-10-29. Estimated completion is 2024-06-19.

What conditions does trial NCT03938324 study?

This clinical trial studies the following conditions: Sickle Cell Disease, Cystic Fibrosis, Diabetes Mellitus, Type 1, Systemic Lupus Erythematosus, Chronic Kidney Diseases.

What interventions are being tested in trial NCT03938324?

The interventions under investigation include: PiCASO Intervention Group (BEHAVIORAL), Sham Comparator: Attention Control Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT03938324?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03938324 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sickle Cell Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.